Emvenio Research, Inc. — Form D/A
Emvenio Research, Inc. of SPARKS, NV, a company, filed a Form D amendment with the SEC on 2022-12-06. The offering totals $10.0M, of which $9.2M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2022-12-06
- Form: D/A
- Accession: 0001943068-22-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $9.2M
- Remaining: $828K
- Minimum investment: $50K
- Investors: 23
- Date of first sale: 2022-08-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-456820
Issuer
- Name: Emvenio Research, Inc.
- CIK: 0001943068
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 255 GLENDALE AVE., SPARKS, NV, 89431
- Phone: 617-947-6756
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Alan Henthorne | Director | Sparks, NV |
| David Shackelton | Director | Sparks, NV |
| Daniel Castillo | Executive Officer | Sparks, NV |
| Alan Henthorne | Executive Officer | Sparks, NV |
| David Shackelton | Executive Officer | Sparks, NV |
| Monty Waugh | Executive Officer | Sparks, NV |
| Thaddeus Wolfram | Executive Officer | Sparks, NV |
Other filings by this issuer (1)
More